Higher levels of TSH associated with reduced stroke risk in type 2 diabetes

Exercising before breakfast may improve weight loss

Growth hormone stimulating drug could help prevent liver disease

23 Oct 2019

According to a study published in The Lancet HIV, an injectable synthetic form of growth-hormone-stimulating hormone, tesamorelin, reduces liver fat and risk of liver fibrosis in patients with HIV.

Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read